Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis: Influenza”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01053377
What this trial is testing

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes

Who this might be right for
Influenza
National Institute for Public Health and the Environment (RIVM) 900
Not applicableWithdrawnNCT00844155
What this trial is testing

Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care Unit

Who this might be right for
Influenza A Virus InfectionInfluenza B Virus Infection
University of Manitoba
Large-scale testing (Phase 3)Looking for participantsNCT07236814
What this trial is testing

Suraxavir Marboxil And Oseltamivir for Influenza Prophylaxis Under a Hospital-based Setting

Who this might be right for
Influenza
Capital Medical University 384
Not applicableStudy completedNCT00778297
What this trial is testing

Immunogenicity and Tolerability Study of FluvalAB FL-K-004 Trivalent Influenza Vaccine

Who this might be right for
Influenza
Fluart Innovative Vaccine Ltd, Hungary 234
Not applicableStudy completedNCT00306982
What this trial is testing

Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™

Who this might be right for
Influenza
GlaxoSmithKline 1,524
Early research (Phase 1)Study completedNCT01405885
What this trial is testing

DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

Who this might be right for
Healthy
Inovio Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT06873282
What this trial is testing

Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine

Who this might be right for
Tuberculosis
Research Institute of Influenza, Russia 160
Post-approval studies (Phase 4)Study completedNCT00812110
What this trial is testing

Influenza Vaccination for Parents and Other Caregivers in the Pediatric Medical Home

Who this might be right for
Influenza
Akron Children's Hospital 336
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)Ended earlyNCT02883426
What this trial is testing

Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 1
Not applicableStudy completedNCT02243774
What this trial is testing

Mail Outreach To Increase Vaccination Acceptance Through Engagement

Who this might be right for
Influenza, HumanInfluenzaHuman Flu
Brigham and Women's Hospital 228,000
Testing effectiveness (Phase 2)Study completedNCT00620815
What this trial is testing

Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
Novartis Vaccines 601
Post-approval studies (Phase 4)Study completedNCT03158038
What this trial is testing

Study to Evaluate the Safety of 1 New 6:2 Influenza Virus Reassortant in Adults for the 2017-2018 Season

Who this might be right for
InfluenzaHealthy
MedImmune LLC 300
Large-scale testing (Phase 3)UnknownNCT01225770
What this trial is testing

Gargling With Green Tea for Prophylaxis of Influenza Infection in Teenagers

Who this might be right for
Influenza Infection
University of Shizuoka 640
Not applicableStudy completedNCT00446628
What this trial is testing

Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children

Who this might be right for
Influenza
Kiren Mitruka 3,360
Testing effectiveness (Phase 2)Study completedNCT02649192
What this trial is testing

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

Who this might be right for
Healthy Participants
St. Jude Children's Research Hospital 87
Early research (Phase 1)Study completedNCT02274545
What this trial is testing

Evaluating the Safety and Immunogenicity of a H7N9 Vaccine for the Prevention of Influenza H7N9 Disease in Adults 50 to 70 Years Old

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT03899571
What this trial is testing

Prophylactic Treatment With Oseltamivir

Who this might be right for
Influenza, Human
University Medical Centre Ljubljana 222
Large-scale testing (Phase 3)Not Yet RecruitingNCT07827599
What this trial is testing

Confirm Efficacy of a Single Dose of Baloxavir Marboxil in the Post-exposure Prophylaxis (PEP) of Influenza Virus Infection in Chinese Participants

Who this might be right for
Influenza, HumanRespiratory Tract InfectionsPost-exposure Prophylaxis
Hoffmann-La Roche 325
Large-scale testing (Phase 3)Study completedNCT01959945
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Who this might be right for
Influenza
Protein Sciences Corporation 219
Next Page